ArticleMolecular plant pathology2026
Xanthomonas Type III Effector XopN Targets Scaffold Protein OsRACK1B to Suppress Rice Immunity.
Article in Molecular plant pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Bacterial leaf streak (BLS), caused by Xanthomonas oryzae pv. oryzicola (Xoc), is a major bacterial disease that poses a substantial threat to rice production. Although Xoc deploys a repertoire of effector proteins to subvert host defences, the mechanisms by which these effectors modulate plant immune signalling remain largely unclear. Here, we demonstrate that the Xoc effector XopN acts as a critical suppressor of rice basal immunity. Using yeast two-hybrid screening, bimolecular fluorescence complementation, and pull-down assays, we identified the WD40-repeat scaffold protein OsRACK1B as a direct target of XopN. Functional analyses revealed that OsRACK1B overexpression enhanced rice resistance to Xoc, whereas loss-of-function mutants exhibited heightened susceptibility. This increased susceptibility was characterised by compromised immunity, including reduced callose deposition, diminished reactive oxygen species (ROS) accumulation, and attenuated expression of defence-related genes such as OsPBZ1 and OsPAL1. Furthermore, we show that OsRACK1B physically associates with OsRap2.6, an AP2/ERF-type transcription factor essential for rice innate immunity. Mechanistically, XopN competes with OsRap2.6 for binding to OsRACK1B, thereby disrupting the formation of the OsRACK1B-OsRap2.6 immune module. Our findings uncover a virulence strategy whereby XopN subverts host basal immunity by targeting a conserved scaffold-mediated complex, providing fundamental insights into the molecular basis of Xoc pathogenicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.